دوره 31، شماره 144 - ( 10-1401 )                   جلد 31 شماره 144 صفحات 13-1 | برگشت به فهرست نسخه ها

XML English Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Amiri Dashatan N, Ashrafmansouri M, Koushki M, Ahmadi N. Effect of Resveratrol and Its Derivatives on Leishmania Viability: A Meta-Analysis. J Adv Med Biomed Res 2023; 31 (144) :1-13
URL: http://journal.zums.ac.ir/article-1-6661-fa.html
Effect of Resveratrol and Its Derivatives on Leishmania Viability: A Meta-Analysis. Journal of Advances in Medical and Biomedical Research. 1401; 31 (144) :1-13

URL: http://journal.zums.ac.ir/article-1-6661-fa.html

Effect of Resveratrol and Its Derivatives on Leishmania Viability: A Meta-Analysis
چکیده:   (11915 مشاهده)

Background and Objective: Leishmaniasis is among the seven more significant tropical diseases, and it is a major global health issue with a wide range of clinical symptoms and potentially lethal consequences. Resveratrol and its derivatives have been shown to have anti-Leishmanial properties. This study aimed to use a meta-analysis of relevant papers to determine the leishmanicidal impact of resveratrol and its derivatives.
Materials and Methods: A comprehensive search method was used to query the electronic databases of PubMed, ScienceDirect, Embase, ISI Web of Science, and Scopus up until June 2021. The articles that met the inclusion criteria were chosen. Random-effects models were used to calculate mean differences in IC50 (concentration corresponding to a 50% reduction in Leishmania) for each outcome. The Newcastle-Ottawa Scale was used to assess the quality of the evidence. To assess heterogeneity and the stability of the pooled data, sensitivity and subgroup analyses were performed. The Egger's and Begg's tests were used to assess publication bias.
Results: In the meta-analysis, nine studies were considered. Resveratrol (RSV) and its derivatives significantly reduced survivability in Leishmania promastigote [24.02 mg/ml; (95% CI 17.1, 30.8); P<0.05; I2 = 99.8%; P Heterogeneity = 0.00] and amastigote [18.3 mg/ml; (95% CI 13.5, 23.2); P<0.05; I2 = 99.6%; P Heterogeneity= 0.00]. The meta-analysis revealed a considerable publication bias. Sensitivity analyses revealed that the effect magnitude was similar, but the heterogeneity was reduced. According to subgroup analysis, the pooled effect sizes of leishmanicidal resveratrol and its derivatives were altered by the kind of stilbenes and Leishmania species.
Conclusion: According to the findings of this meta-analysis, RSV and its derivatives could be a possible therapeutic option for leishmaniasis. However, more research is needed to confirm and employ this chemical against Leishmania.

متن کامل [PDF 1001 kb]   (10738 دریافت)    
نوع مطالعه: مقاله مروری | موضوع مقاله: Pharmacology
دریافت: 1400/5/23 | پذیرش: 1401/5/4 | انتشار: 1401/9/21
فهرست منابع
1. Organization WH. Leishmaniasis-Key facts. 2020. 2020.
2. Showler AJ, Boggild AK. Cutaneous leishmaniasis in travellers: a focus on epidemiology and treatment in 2015. Curr Infect Disease Rep. 2015;17(7):1-12. [DOI:10.1007/s11908-015-0489-2] [PMID]
3. Steverding D. The history of leishmaniasis. Parasites & Vectors. 2017;10(1):1-10. [DOI:10.1186/s13071-017-2028-5] [PMID] [PMCID]
4. Amiri-Dashatan N, Koushki M, Rezaei Tavirani M, Ahmadi N. Proteomic-based studies on Leishmania. J Mazandaran Univ Med Sci. 2018;28(163):173-90.
5. Atan NAD, Koushki M, Ahmadi NA, Rezaei-Tavirani M. Metabolomics-based studies in the field of Leishmania/leishmaniasis. Alexandria J Med. 2018;54(4):383-90. [DOI:10.1016/j.ajme.2018.06.002]
6. Walker J, Gongora R, Vasquez JJ, et al. Discovery of factors linked to antimony resistance in Leishmania panamensis through differential proteome analysis. Molec Biochem Parasitol. 2012;183(2):166-76. [DOI:10.1016/j.molbiopara.2012.03.002] [PMID]
7. Mishra M, Biswas U, Jha D, Khan A. Amphotericin versus pentamidine in antimony-unresponsive kala-azar. The Lancet. 1992;340(8830):1256-7. [DOI:10.1016/0140-6736(92)92952-C]
8. Sundar S, Chakravarty J. Liposomal amphotericin B and leishmaniasis: dose and response. J Glob Infect Disease. 2010;2(2):159. [DOI:10.4103/0974-777X.62886] [PMID] [PMCID]
9. Lindoso JAL, Costa JML, Queiroz IT, Goto H. Review of the current treatments for leishmaniases. Res Rep Trop Med. 2012;3:69. [DOI:10.2147/RRTM.S24764] [PMID] [PMCID]
10. Oliveira LF, Schubach AO, Martins MM, et al. Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World. Acta Tropica. 2011;118(2):87-96. [DOI:10.1016/j.actatropica.2011.02.007] [PMID]
11. Sundar S, Singh A, Rai M, et al. Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use. Clin Infect Disease. 2012;55(4):543-50. [DOI:10.1093/cid/cis474] [PMID]
12. Dashatan NA, Tavirani MR, Zali H, Koushki M, Ahmadi N. Prediction of Leishmania major key proteins via topological analysis of protein-protein interaction network. Galen Med J. 2018;7:e1129. [DOI:10.31661/gmj.v7i0.1129]
13. Khoramie NAA. The effects of essential oil of Lavandula angustifolia on sperm parameters quality and reproductive hormones in rats exposed to cadmium. J Rep Pharmaceut Sci. 2015;4(2):121-8.
14. Fuchino H, Kiuchi F, Yamanaka A, et al. New leishmanicidal stilbenes from a Peruvian folk medicine, Lonchocarpus nicou. Chem Pharm Bull (Tokyo). 2013;61(9):979-82. [DOI:10.1248/cpb.c13-00385] [PMID]
15. Kuršvietienė L, Stanevičienė I, Mongirdienė A, Bernatonienė J. Multiplicity of effects and health benefits of resveratrol. Medicina. 2016;52(3):148-55. [DOI:10.1016/j.medici.2016.03.003] [PMID]
16. Wu Y, Liu F. Targeting mTOR: evaluating the therapeutic potential of resveratrol for cancer treatment. Anti-Cancer Agents Med Chem. 2013;13(7):1032-8. [DOI:10.2174/18715206113139990113] [PMID]
17. Lucas IK, Kolodziej H. In vitro antileishmanial activity of resveratrol originates from its cytotoxic potential against host cells. Planta Medica. 2013;79(01):20-6. [DOI:10.1055/s-0032-1328020] [PMID]
18. Rasouli HR, Manoochehry S, Ahmadpour F, Abbasi Farajzadeh M. The importance of meta-analysis in medical research. Int J Med Rev. 2017;4(4):126-. [DOI:10.29252/IJMR-040407]
19. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336-41. [DOI:10.1016/j.ijsu.2010.02.007] [PMID]
20. Wells GA, Tugwell P, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. 2015.
21. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-34. [DOI:10.1136/bmj.315.7109.629] [PMID] [PMCID]
22. Kedzierski L, Curtis JM, Kaminska M, Jodynis-Liebert J, Murias M. In vitro antileishmanial activity of resveratrol and its hydroxylated analogues against Leishmania major promastigotes and amastigotes. Parasitol Res. 2007;102(1):91-7. [DOI:10.1007/s00436-007-0729-y] [PMID]
23. Ferreira C, Soares DC, do Nascimento MTC, et al. Resveratrol is active against Leishmania amazonensis: in vitro effect of its association with amphotericin B. Antimicrob Agents Chemother. 2014;58(10):6197-208. [DOI:10.1128/AAC.00093-14] [PMID] [PMCID]
24. Passos CLA, Ferreira C, Soares DC, Saraiva EM. Leishmanicidal effect of synthetic trans-resveratrol analogs. PloS one. 2015;10(10). [DOI:10.1371/journal.pone.0141778] [PMID] [PMCID]
25. Coimbra ES, Santos JA, Lima LL, et al. Synthesis, antitubercular and leishmanicidal evaluation of resveratrol analogues. J Brazil Chem Soc. 2016;27(12):2161-9. [DOI:10.5935/0103-5053.20160107]
26. Castelli G, Bruno F, Vitale F, et al. In vitro antileishmanial activity of trans-stilbene and terphenyl compounds. Experiment Parasitol. 2016;166:1-9. [DOI:10.1016/j.exppara.2016.03.007] [PMID]
27. Bruno F, Castelli G, Vitale F, et al. Effects of trans-stilbene and terphenyl compounds on different strains of Leishmania and on cytokines production from infected macrophages. Experiment Parasitol. 2018;184:31-8. [DOI:10.1016/j.exppara.2017.11.004] [PMID]
28. Antinarelli LMR, Meinel RS, Coelho EAF, da Silva AD, Coimbra ES. Resveratrol analogues present effective antileishmanial activity against promastigotes and amastigotes from distinct Leishmania species by multitarget action in the parasites. J Pharmacy Pharmacol. 2019;71(12):1854-63. [DOI:10.1111/jphp.13177] [PMID]
29. Tolomeo M, Roberti M, Scapozza L, et al. TTAS a new stilbene derivative that induces apoptosis in Leishmania infantum. Experiment Parasitol. 2013;133(1):37-43. [DOI:10.1016/j.exppara.2012.10.006] [PMID]
30. Koushki M, Amiri‐Dashatan N, Ahmadi N, Abbaszadeh HA, Rezaei‐Tavirani M. Resveratrol: A miraculous natural compound for diseases treatment. Food Sci Nutr. 2018;6(8):2473-90. [DOI:10.1002/fsn3.855] [PMID] [PMCID]
31. Devaux PF. Static and dynamic lipid asymmetry in cell membranes. Biochem. 1991;30(5):1163-73. [DOI:10.1021/bi00219a001] [PMID]
32. Weingärtner A, Kemmer G, Müller FD, et al. Leishmania promastigotes lack phosphatidylserine but bind annexin V upon permeabilization or miltefosine treatment. PloS one. 2012;7(8). [DOI:10.1371/journal.pone.0042070] [PMID] [PMCID]
33. Wanderley JLM, da Silva LHP, Deolindo P, et al. Cooperation between apoptotic and viable metacyclics enhances the pathogenesis of Leishmaniasis. PloS one. 2009;4(5). [DOI:10.1371/journal.pone.0005733] [PMID] [PMCID]
34. de Freitas Balanco JM, Moreira MEC, Bonomo A, et al. Apoptotic mimicry by an obligate intracellular parasite downregulates macrophage microbicidal activity. Curr Biol. 2001;11(23):1870-3. [DOI:10.1016/S0960-9822(01)00563-2]
35. Wanderley JLM, Thorpe PE, Barcinski MA, Soong L. Phosphatidylserine exposure on the surface of L eishmania amazonensis amastigotes modulates in vivo infection and dendritic cell function. Parasite Immunol. 2013;35(3-4):109-19. [DOI:10.1111/pim.12019] [PMID] [PMCID]
36. Fadeel B, Xue D. The ins and outs of phospholipid asymmetry in the plasma membrane: roles in health and disease. Crit Rev Biochem Molec Biol. 2009;44(5):264-77. [DOI:10.1080/10409230903193307] [PMID] [PMCID]
37. Ambit A, Fasel N, Coombs G, Mottram J. An essential role for the Leishmania major metacaspase in cell cycle progression. Cell Death Different. 2008;15(1):113-22. [DOI:10.1038/sj.cdd.4402232] [PMID]
بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به Journal of Advances in Medical and Biomedical Research می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2025 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb